Immupharma PLC Notice of AGM and posting of Report & Accounts (9079A)

TIDMIMM

RNS Number : 9079A

Immupharma PLC

04 June 2019

4 JUNE 2019

ImmuPharma PLC

("ImmuPharma" or the "Company")

Notice of AGM and posting of Report & Accounts

ImmuPharma PLC (LSE:IMM), ("ImmuPharma" or the "Company"), the specialist drug discovery and development company confirms that the Annual Report and Accounts for the year ended 31 December 2018, and the Notice of Annual General Meeting has been posted to shareholders.

These documents are available, in electronic form, for download on the Company's website www.immupharma.co.uk.

ImmuPharma's Annual General Meeting will be held on Thursday 27 June at 10:30am (BST) at the offices of: Capital Access Group, 107 Cheapside, London, EC2V 6DN.

 
 
    For further information please contact: 
     ImmuPharma PLC (www.immupharma.com)            + 44 (0) 207 152 4080 
     Tim McCarthy, Chairman 
      Dimitri Dimitriou, Chief Executive Officer 
     Lisa Baderoon, Head of Investor Relations      + 44 (0) 7721 413496 
     SPARK Advisory Partners Limited (NOMAD) 
      Neil Baldwin                                  +44 (0) 203 368 8974 
      Vassil Kirtchev 
      Stanford Capital Partners (Joint Broker) 
      Patrick Claridge, John Howes                   +44 (0) 203 815 8880 
 
      SI Capital (Joint Broker) 
      Nick Emerson                                   +44 (0) 1483 413500

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DOCUORWRKOANRRR

(END) Dow Jones Newswires

June 04, 2019 02:00 ET (06:00 GMT)

Immupharma (LSE:IMM)
Historical Stock Chart
From May 2024 to Jun 2024